Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site discolouration, Vaccination site pruritus
Clinical narrative: Her face paralyzed for three days after the injection; Skin discoloration and itching that are still present; Impaired her from eating; Chest Pain; General weakness; Sweating; Skin discoloration and itching that are still present; Strong nausea; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PARALYSIS (Her face paralyzed for three days after the injection) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011O21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jul-2021, the patient experienced FACIAL PARALYSIS (Her face paralyzed for three days after the injection) (seriousness criterion medically significant), VACCINATION SITE DISCOLOURATION (Skin discoloration and itching that are still present), DECREASED APPETITE (Impaired her from eating), CHEST PAIN (Chest Pain), ASTHENIA (General weakness), HYPERHIDROSIS (Sweating), VACCINATION SITE PRURITUS (Skin discoloration and itching that are still present) and NAUSEA (Strong nausea). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, FACIAL PARALYSIS (Her face paralyzed for three days after the injection), DECREASED APPETITE (Impaired her from eating), CHEST PAIN (Chest Pain), HYPERHIDROSIS (Sweating) and NAUSEA (Strong nausea) outcome was unknown and VACCINATION SITE DISCOLOURATION (Skin discoloration and itching that are still present), ASTHENIA (General weakness) and VACCINATION SITE PRURITUS (Skin discoloration and itching that are still present) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not provided  The patient experienced chest pain and was landed her in ER where she was tested and all the results were normal.  Patient reported adverse events after the Moderna Covid-19 vaccine was injected 2Jul2021. She reported skin discoloration and itching that are still present, strong nausea that impaired her from eating, sweating and that her face paralyzed for three days after the injection. Finally she reported chest pain that landed her in the emergency room, she was tested and al the results were normal. Since then most of the symptoms persist alongside general weakness.  The vaccine was applied at a pharmacy. Vaccine was administered in the upper left (non dominant)  She has no medical insurance but a relative licensed nurse recommended her to take Benadryl as a response to the  "allergic reaction" that she was experiencing.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. No further information is expected at this time.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. No further information is expected at this time.